RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. LongRiver Investments
L

LongRiver Investments portfolio

LongRiver Investments has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Capital in their rounds: $170M.
Latest deal: Ouro Medicines · Jan 10, 2025.
About this page

Its most recent investment on record is Ouro Medicines's $120M Series A round in January 2025, alongside UPMC Enterprises, Monograph Capital, NEA and 4 others. By category, its portfolio leans toward Health and bio (2). It has co-invested with NEA, Norwest Venture Partners and Monograph Capital.

What LongRiver Investments invests in

How LongRiver Investments invests

StageDealsCapital in rounds
Series A 1 50%$120M
Series B+ 1 50%$50M
YearDealsCapital in rounds
2023 1 50%$50M
2025 1 50%$120M

LongRiver Investments portfolio companies

CompanyRound with LongRiver InvestmentsTotal raisedLatest raise
OOuro Medicines
Health and bio
 Series A · $120M$120MJan 10, 2025
Series A
AAllorion Therapeutics
Health and bio
 Series B+ · $50M$50MMar 10, 2023
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name LongRiver Investments. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists LongRiver Investments, which is a subset of its real portfolio. API: /api/v1/investors/longriver-investments (get a free API key). More: the most active VC firms and new venture capital funds.